Abstract
To investigate coronavirus disease 2019 (COVID-19) in infants aged 0 to 3 months because there is currently a significant gap in the literature on the subject. A cross-sectional study was conducted with the involvement of 19 medical centers across Turkey and 570 infants. The majority of the patients were male (58.2%), and the three most common symptoms were fever (78.2%), cough (44.6%), and feeding intolerance (39.9%). The results showed that a small percentage of infants had positive blood (0.9%) or urine cultures (10.2%). Most infants presented with fever (78.2%). Children without underlying conditions (UCs) had mostly a complicated respiratory course and a normal chest radiography. Significant more positive urine culture rates were observed in infants with fever. A higher incidence of respiratory support requirements and abnormal chest findings were seen in infants with chronic conditions. These infants also had a longer hospital stay than those without chronic conditions.
Conclusions: Our study discloses the clinical observations and accompanying bacterial infections found in infants aged under 3 months with COVID-19. These findings can shed light on COVID-19 in infancy for physicians because there is limited clinical evidence available.
What is Known: • COVID-19 in infants and older children has been seen more mildly than in adults. • The most common symptoms of COVID-19 in infants are fever and cough, as in older children and adults. COVID-19 should be one of the differential diagnoses in infants with fever. | |
What is New: • Although most infants under three months had fever, the clinical course was uneventful and respiratory complications were rarely observed in healthy children. • Infants with underlying conditions had more frequent respiratory support and abnormal chest radiography and stayed longer in the hospital. |
Similar content being viewed by others
Data availability
Not applicable.
Code availability
Not applicable.
Abbreviations
- CDC:
-
Centers for Disease Control and Prevention
- COVID-19:
-
Coronavirus disease 2019
- CSF:
-
Cerebrospinal fluid
- IQR:
-
Interquartile range
- MIS-C:
-
Multisystem inflammatory syndrome in children
- PCR:
-
Polymerase chain reaction
- RSV:
-
Respiratory syncytial virus
- SARS-CoV-2:
-
Severe acute respiratory syndrome coronavirus 2
- WHO:
-
World Health Organization
References
Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S (2020) Epidemiology of COVID-19 among children in China. Pediatrics 145:e20200702. https://doi.org/10.1542/peds.2020-0702
Ladhani SN, Amin-Chowdhury Z, Davies HG et al (2020) COVID-19 in children: analysis of the first pandemic peak in England. Arch Dis Child 105:1180–1185. https://doi.org/10.1136/archdischild-2020-320042
Cui X, Zhao Z, Zhang T et al (2021) A systematic review and meta-analysis of children with coronavirus disease 2019 (COVID-19). J Med Virol 93:1057–1069. https://doi.org/10.1002/jmv.26398
Kanburoglu MK, Tayman C, Oncel MY et al (2020) A multicentered study on epidemiologic and clinical characteristics of 37 neonates with community-acquired COVID-19. Pediatr Infect Dis J 39:e297–e302. https://doi.org/10.1097/INF.0000000000002862
McLaren SH, Dayan PS, Fenster DB, Vindas OJB, MT, Bugaighis MN, Gonzalez AE, Lubell TR, (2020) Novel coronavirus infection in febrile infants aged 60 days and younger. Pediatrics 146:e20201550. https://doi.org/10.1542/peds.2020-1550
Spoulou V, Noni M, Koukou D, Michos KA, A, (2021) Clinical characteristics of COVID-19 in neonates and young infants. Eur J Pediatr 180:3041–3045. https://doi.org/10.1007/s00431-021-04042-x
Henderson LA, Canna SW, Friedman KG et al (2021) American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 2. Arthritis Rheumatol 73:e13–e29. https://doi.org/10.1002/art.41616
Blázquez-Gamero D, Epalza C, Cadenas JAA et al (2021) Fever without source as the first manifestation of SARS-CoV-2 infection in infants less than 90 days old. Eur J Pediatr 180:2099–2106. https://doi.org/10.1007/s00431-021-03973-9
Paret M, Lalani K, Hedari C et al (2021) SARS-CoV-2 among infants <90 days of age admitted for serious bacterial infection evaluation. Pediatrics 148:e2020044685. https://doi.org/10.1542/peds.2020-044685
World Health Organization (WHO) (2023) Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic. https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic. Accessed 3 July 2023
Dona’ D, Montagnani C, Di Chiara C et al (2022) On Behalf Of The Italian Sitip-Sip Pediatric Sars-CoV-Infection Study Group. COVID-19 in infants less than 3 months: severe or not severe disease?. Viruses 14:2256. https://doi.org/10.3390/v14102256
Yılmaz D, Üstündağ G, Büyükçam A et al (2023) A snapshot of pediatric inpatients and outpatients with COVID-19: a point prevalence study from Turkey. Eur J Pediatr 182:3231–3242. https://doi.org/10.1007/s00431-023-04982-6
Rahman S, Montero MTV, Rowe K, Kirton R, Kunik F Jr (2021) Epidemiology, pathogenesis, clinical. presentations, diagnosis and treatment of COVID-19: a review of current evidence. Expert Rev Clin Pharmacol 14:601–621. https://doi.org/10.1080/17512433.2021.1902303
Sahin A, Karadag-Oncel E, Buyuksen O et al (2023) The diversity in the clinical features of children hospitalized with COVID-19 during the nonvariant, Alpha (B.1.1.7), Delta (B.1.617.2), and Omicron (B.1.1.529) variant periods of SARS CoV-2: caution for neurological symptoms in Omicron variant. J Med Virol 95:e28628. https://doi.org/10.1002/jmv.28628
Akin IM, Kanburoglu MK, Tayman C et al Neo-Covid Study Group (2022) Epidemiologic and clinical characteristics of neonates with late-onset COVID-19: 1-year data of Turkish Neonatal Society. Eur J Pediatr 181:1933–1942. https://doi.org/10.1007/s00431-021-04358-8
Centers for Disease Control and Prevention (CDC) (2023) Information for healthcare providers about multisystem inflammatory syndrome in children (MIS-C). https://www.cdc.gov/mis/mis-c/hcp_cstecdc/index.html. Accessed 3 July 2023
Gustine JN, Jones D (2021) Immunopathology of hyperinflammation in COVID-19. Am J Pathol 191:4–17. https://doi.org/10.1016/j.ajpath.2020.08.009
Wu HY, Chang PH, Chen KY, Lin IF, Hsih WH, Tsai WL, Chen JA, Lee SS, GREAT working group, (2022) Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: incidence, diagnosis and treatment. J Microbiol Immunol Infect 5:985–992. https://doi.org/10.1016/j.jmii.2022.09.006
Benenson-Weinberg T, Gross I, Bamberger Z, Guzner N, Wolf D, Gordon O, Nama A, Hashavya S (2023) Severe acute respiratory syndrome coronavirus 2 in infants younger than 90 days presenting to the pediatric emergency department: clinical characteristics and risk of serious bacterial infection. Pediatr Emerg Care. https://doi.org/10.1097/PEC.0000000000002940
Petrarca L, Nenna R, Frassanito A, Pierangeli A, Leonardi S, Scagnolari C, Antonelli G, Papoff P, Moretti C, Midulla F (2018) Acute bronchiolitis: influence of viral co-infection in infants hospitalized over 12 consecutive epidemic seasons. J Med Virol 90(4):631–638. https://doi.org/10.1002/jmv.24994. Epub 2017 Dec 11. PMID: 29226974; PMCID: PMC7166564.
Di Sarno L, Curatola A, Conti G et al (2022) The effects of COVID-19 outbreak on pediatric emergency department admissions for acute wheezing. Pediatr Pulmonol 57:1167–1172. https://doi.org/10.1002/ppul.25858
Wrotek S, LeGrand EK, Dzialuk A, Alcock J (2020) Let fever do its job: the meaning of fever in the pandemic era. Evol Med Public Health 9:26–35. https://doi.org/10.1093/emph/eoaa044
Harden LM, Kent S, Pittman QJ (2015) Roth J (2015) Fever and sickness behavior: friend or foe? Brain Behav Immun 50:322–333. https://doi.org/10.1016/j.bbi.2015.07.012
Choi JH, Choi SH, Yun KW (2022) Risk factors for severe COVID-19 in children: a systematic review and meta-analysis. J Korean Med Sci 37:e35. https://doi.org/10.3346/jkms.2022.37.e35
Tsankov BK, Allaire JM, Irvine MA, Lopez AA, Sauvé LJ, Vallance BA, Jacobson K (2021) Severe COVID-19 infection and pediatric comorbidities: a systematic review and meta-analysis. Int J Infect Dis 103:246–256. https://doi.org/10.1016/j.ijid.2020.11.163
Piché-Renaud PP, Panetta L, Farrar DS et al (2022) Canadian Paediatric Surveillance Program COVID-19 Study Team. Clinical manifestations and disease severity of SARS-CoV-2 infection among infants in Canada. PLoS One 17(8):e0272648. https://doi.org/10.1371/journal.pone.0272648
CV Hobbs K Woodworth CC Young et al (2022) for the Overcoming COVID-19 Investigators Frequency, characteristics and complications of COVID-19 in hospitalized infants. Pediatr Infect Dis J 41 3 e81 e86 https://doi.org/10.1097/INF.0000000000003435
Author information
Authors and Affiliations
Contributions
All authors have made substantial contributions to all the following: (1) the conception and design of the study, acquisition of data or analysis, and interpretation of data; (2) drafting of the article or critical review of it for important intellectual content; and (3) final approval of the submitted version.
Corresponding author
Ethics declarations
Ethics approval
The pediatric infectious disease clinic at Health Science University Izmir Tepecik Training and Research Hospital managed the research, which received ethical approval (decision number: 2022/12–19). Our hospital’s ethics committee unit was emailed data from the centers, and ethical approval documents with wet signatures from each participant center were mailed to the unit. All investigative procedures adhered to the principles outlined in the Declaration of Helsinki.
Consent to participate
Not applicable.
Consent for publication
All the patient data are anonymized, and parents and legal guardians consented to publication of the results of the project.
Competing interests
The authors declare no competing interests.
Additional information
Communicated by Peter de Winter
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Üstündağ, G., Karadag-Oncel, E., Kara-Ulu, N. et al. COVID-19 in hospitalized infants aged under 3 months: multi-center experiences across Turkey. Eur J Pediatr 183, 1153–1162 (2024). https://doi.org/10.1007/s00431-023-05329-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-023-05329-x